Veeva Systems Inc

Latest Results (23.10.2025):

Veeva Systems Inc. announced its Fiscal 2026 Second Quarter results, reporting total revenues of $789.1 million, a 17% increase year-over-year. Subscription services revenues also grew by 17% to $659.2 million, reflecting the company's ongoing growth in the life sciences cloud solutions market.

Revenue Growth

In the second quarter, Veeva achieved total revenues of $789.1 million, up from $676.2 million a year earlier. Subscription services contributed $659.2 million to the total, marking a consistent 17% year-over-year growth.

Increased Operating and Net Income

Operating income rose by 18% to $195.9 million, while net income increased 17% to $200.3 million compared to the same period last year. Non-GAAP metrics showed even stronger growth, with non-GAAP operating income up 26% and non-GAAP net income up 25% year-over-year.

Advancements in Veeva AI and Cloud Solutions

Veeva continues to innovate with its Veeva AI and Veeva Data Cloud offerings, planning the release of Veeva AI agents for CRM and commercial content in December. Future expansions for clinical operations and other areas are scheduled through 2027.

Expansion of Vault CRM Suite

The Vault CRM Suite surpassed 100 live customers, including several top 20 biopharmaceutical companies. New features like Patient CRM and enhancements such as Campaign Manager and Service Center have been successfully deployed.

Strategic Partnership with IQVIA

Veeva and IQVIA have entered into a long-term global partnership, resolving all pending legal disputes. This collaboration will enable joint customers to seamlessly integrate Veeva and IQVIA products across commercial and clinical operations.